Free radicals are waste products produced by the body's reaction to outside toxins or processing food that can damage cells and eventually lead to disease

According to Yucca Health's safety information pages, GLP-1 medications like semaglutide and tirzepatide have important contraindications: Do not use if: You or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) You have had a severe allergic reaction to semaglutide, tirzepatide, or any ingredients in the formulation You are pregnant, planning to become pregnant, or breastfeeding (GLP-1 medications are not recommended during pregnancy or breastfeeding) Use with caution and close medical supervision if you have: History of pancreatitis or pancreas problems Kidney problems or history of kidney disease Severe gastrointestinal issues such as gastroparesis Type 2 diabetes with history of diabetic retinopathy (semaglutide specifically) Are taking other medications including insulin or sulfonylureas (increased risk of hypoglycemia) The provider reviewing your intake will screen for these factors and may decline to prescribe if contraindications are present or request additional information before making a determination

InRange: Comparison of the second-generation basal insulin analogues glargine 300 U/mL and degludec 100 U/mL in persons with type 1 diabetes using continuous glucose monitoring-study design
In animal studies, even very high doses (up to 1020 mg/kg administered intramuscularly) did not produce acute toxicity or histological alterations in major organs
At steady state, average blood levels are higher and more stable than after the first dose, which often translates into smoother appetite and glucose effectsand sometimes more noticeable GI side effects during dose increases